Investment Analysis
2 articles on Investment Analysis, written by Shotlee and medically reviewed for clinical accuracy.
Finance
Should You Invest in Novo Nordisk, the Ozempic Manufacturer, in 2026?
Investing in Novo Nordisk (NVO), the maker of Ozempic and Wegovy, has faced challenges recently, with shares declining. However, recent FDA approval of an oral form of Wegovy could change the company's trajectory. Analyzing competition and market dynamics is vital for investment decisions.
2 min read
Finance
Jim Cramer: Eli Lilly's GLP-1 Pill Will 'Revolutionize Everything'
Jim Cramer commented on Eli Lilly's GLP-1 pill, anticipating a revolutionary impact. He also assessed other portfolio holdings, including Taiwan Semi, Chevron, SL Green, and Microsoft, providing insights into their respective sectors.
2 min read